The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $81.20

Today's change+0.19 +0.23%
Updated July 1 9:46 AM EDT. Delayed by at least 15 minutes.
 

Quest Diagnostics Inc

NYSE: DGX
Last

(U.S.) $81.20

Today's change+0.19 +0.23%
Updated July 1 9:46 AM EDT. Delayed by at least 15 minutes.

Quest Diagnostics Inc Hits New 52-week High

Quest Diagnostics Inc is up today by (U.S.)$0.19 or 0.23% to (U.S.)$81.20 and setting a new 52-week high. Over the last five days, shares have gained 2.92% and 14.14% year to date. Shares have outperformed the S&P 500 by 10.11% during the last year.

Key company metrics

  • Open(U.S.) $80.89
  • Previous close(U.S.) $81.01
  • High(U.S.) $81.31
  • Low(U.S.) $80.79
  • Bid / Ask(U.S.) $81.17 / (U.S.) $81.21
  • YTD % change+14.14%
  • Volume42,969
  • Average volume (10-day)1,675,137
  • Average volume (1-month)1,352,819
  • Average volume (3-month)1,086,521
  • 52-week range(U.S.) $59.66 to (U.S.) $81.41
  • Beta0.70
  • Trailing P/E15.74×
  • P/E 1 year forward15.98×
  • Forward PEG2.07×
  • Indicated annual dividend(U.S.) $1.60
  • Dividend yield1.97%
  • Trailing EPS(U.S.) $5.16
Updated July 1 9:46 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.20%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue1,8631,8491,8801,925
Total other revenue--------
Total revenue1,8631,8491,8801,925
Gross profit720702730747
Total cost of revenue1,1431,1471,1501,178
Total operating expense1,6061,6101,2491,624
Selling / general / administrative440429399427
Research & development--------
Depreciation / amortization19202020
Interest expense (income), net operating--------
Unusual expense (income)33-3196
Other operating expenses, total111-1-7
Operating income257239631301
Interest income (expense), net non-operating---36-35-37
Gain (loss) on sale of assets--------
Other--------
Income before tax182214593207
Income after tax114200354129
Income tax, total681423978
Net income102188342118
Total adjustments to net income00-2-1
Net income before extra. items102188342118
Minority interest-12-12-12-11
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items102188340117
Inc. avail. to common incl. extra. items102188340117
Diluted net income102188340117
Dilution adjustment------0
Diluted weighted average shares144145145145
Diluted EPS excluding extraordinary itemsvalue per share0.711.302.340.81
Dividends per sharevalue per share0.400.380.380.38
Diluted normalized EPSvalue per share0.721.321.030.84